Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 207-214, May 2007

Averting iatrogenic hypoglycemia through glucose prediction in clinical practice: Progress towards a new procedure in diabetes

  • A.M. Albisser

      Affiliations

    • Shared Diabetes Data Center, Hollywood, FL, United States
    • Corresponding Author InformationCorresponding author at: Shared Diabetes Data Center, BCMC Better Control Medical Computers, Inc., 1400 South Ocean Drive, Unit 604, Hollywood Beach, FL 33019, United States. Tel.: +1 954 270 2662.
  • ,
  • C.E. Wright

      Affiliations

    • Metabolic Care Center, Greenville, PA, United States
  • ,
  • S. Sakkal

      Affiliations

    • Metabolic Care Center, Greenville, PA, United States

Received 2 July 2006; accepted 4 September 2006. published online 06 October 2006.

Abstract 

Background

Hypoglycemia is a risk factor common to all insulin therapy. The hypothesis is that efforts to reduce or prevent this adverse side effect may fail because providers generally lack the resources to predict not only future blood glucose levels but also future risks of hypoglycemia. This lack has been remedied. A controlled study was undertaken to test the hypothesis.

Methods

Twenty-two insulin dependent subjects suffering more than one (1) episode/week of hypoglycemia with similar insulin regimens, similar diabetes education and similar self-management training participated in this study. For all subjects, a remote monitoring resource (registry and database) was used to capture daily SMBG and afford a return path for provider interventions and decision support. Identical telemedical methods were used which differed only for the provider either by the presence (prediction group) or by the absence (control group) of an on-screen, visual display of predicted glycemia and predicted risks of hypoglycemia. The study lasted 2 months.

Results

Over an average of 41 days from baseline to follow up and while using the glycemic prediction resource, providers intervened more effectively in the prediction group reducing rates of hypoglycemia nine-fold (P<0.0001) and insulin therapy by just −9U/day (P<0.01). Mean pre-meal glycemia was not compromised. Over 61 days from baseline to final follow up but without glycemic predictions in the control group, providers’ interventions were less effective and resulted in no net changes in rates of hypoglycemia, daily insulin therapy, or mean pre-meal glycemia.

Conclusions

Given knowledge of future glycemia and future risks of hypoglycemia, providers in clinical practice can now avert iatrogenic hypoglycemia in less than 2 months. A shared diabetes data center furnishing remote data capture and decision support is fundamental to the implementation of this as a new clinical procedure in diabetes.

Keywords: Blood glucose control, Telemedicine, IVR, Models, Algorithms, Glucose monitoring, Diabetes control, Intervention, Insulin resistance, Hypoglycemia unawareness, Disease management, Outcome measure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(06)00390-1

doi:10.1016/j.diabres.2006.09.007

Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 207-214, May 2007